Suchergebnisse - "Vasudevan, Abhinav"

PubPharm (11)

1

Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease : A proof-of-concept study

enthalten in: World journal of gastroenterology | 2021

von Con, D. | van Langenberg, D. | Vasudevan, A.

2

Assessing adherence to infusion-based biologic therapies in patients with inflammatory bowel disease

enthalten in: Research in social & administrative pharmacy : RSAP | 2021

von Haar, G. | Vasudevan, A. | Curtain, C. | +1

3

Approach to medical therapy in perianal Crohn's disease

enthalten in: World journal of gastroenterology | 2021

von Vasudevan, A. | Bruining, D. | Loftus, E. | +3

4

Response to : Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Con, D. | Van Langenberg, D. | Vasudevan, A.

CommentOn: Clin Gastroenterol Hepatol. 2021 Feb;19(2):288-295.e4. - PMID 32200087

5

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab : A stepwise, safety and patient-orientated process towards sustainability

enthalten in: World journal of gastroenterology | 2020

von Bohra, A. | Rizvi, Q. | Keung, C. | +2

6

Medical Management of Infliximab Failure in Acute Severe Ulcerative Colitis

enthalten in: Journal of Crohn's & colitis | 2020

von Nicolaides, S. | Vasudevan, A. | Van Langenberg, D.

CommentOn: J Crohns Colitis. 2019 Sep 19;13(9):1105-1110. - PMID 30726894

7

Complex Fistulizing Crohn's Disease

enthalten in: Gastroenterology | 2020

von Apostolov, R. | Nicolaides, S. | Vasudevan, A.

8

The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era

enthalten in: Inflammatory bowel diseases | 2020

von Vasudevan, A. | Ip, F. | Liew, D. | +1

9

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease

enthalten in: Digestive diseases and sciences | 2019

von Vasudevan, A. | Raghunath, A. | Anthony, S. | +4

10

Letter : overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it!

enthalten in: Alimentary pharmacology & therapeutics | 2018

von van Langenberg, D. | Vasudevan, A.

CommentOn: Aliment Pharmacol Ther. 2018 Feb;47(3):346-355. - PMID 29226370